World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Software, data and AI companies at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
17 software, data and AI companies are at World CDx 2026 — 15 presentations on the program. Most represented: Microsoft (2 on the program), Bioptimus (1 on the program), Imagene AI (1 on the program). 15 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–17 of 17 organizations
| Organization | World CDx 2026 Attendance |
|---|---|
Microsoft Redmond, WA | |
Technology company whose cloud, data and AI services are used by healthcare and life science organizations. | Talk Wed Oct 7 11:50am Advancing Pharma Agentic R&D at Scale Multimodal & AI-enabled precision medicine Panel Wed Oct 7 12:50pm Embed, Don’t Disrupt: AI Diagnostics That Scale Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access Panel Wed Oct 7 3:10pm Realizing the Promise, Gaps & Platform Innovation for Precision Medicine at Scale from Global Technology Leaders Multimodal & AI-enabled precision medicine |
Bioptimus Paris, France | ◇Program Partner |
Builds AI foundation models of biology, including H-Optimus for histology images and the multimodal M-Optimus model, used in research and drug discovery. | Talk Wed Oct 7 2:10pm From Spatial Atlases to Predictive Insights: Scaling Precision Medicine with the M-Optimus World Model Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Imagene AI Tel Aviv, Israel | ◇Panel Partner |
Builds AI pathology models and real-world data tools that predict cancer biomarkers from tissue images, including the LungOI lung cancer test. | Panel Wed Oct 7 3:10pm Realizing the Promise, Gaps & Platform Innovation for Precision Medicine at Scale from Global Technology Leaders Multimodal & AI-enabled precision medicine |
Lunit Seoul, South Korea | ◇Program Partner |
South Korean medical AI company with software for cancer screening images and AI analysis of tumor tissue biomarkers. | Talk Thu Oct 8 11:00am Can AI Predict ADC Response? Multimodal & AI-enabled precision medicineBiomarker discovery & translation |
Mindpeak Hamburg, Germany | ◇Program Partner |
Digital pathology company whose AI quantifies biomarkers in H&E, IHC and multiplex immunofluorescence tissue images for research and diagnostics. | Panel Wed Oct 7 11:20am Beyond the Slide: Tissue AI as the Anchor for Multimodal Biomarker Discovery & Global Deployment Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Nucleai Tel Aviv, Israel | ◇Program Partner |
AI pathology and spatial biology company giving drug developers tissue-based insights for biomarker and patient selection strategies, including for ADCs. | Panel Wed Oct 7 2:10pm Beyond IHC Scoring: Unlocking Next-Generation Clinical Biomarkers through AI-Powered Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Panakeia Cambridge, UK | ◇Program Partner |
Builds AI that reads molecular biomarker status directly from H&E tissue images, for clinical diagnostics and drug development. | Panel Wed Oct 7 12:10pm Building the Clinical & Commercial Ecosystem for AI-Enabled Precision Pathology Digital pathology & spatial biomarkersDrug–diagnostic commercialization & access |
Patholytix Dublin, Ireland | ◇Spotlight Partner |
Pathology service from Deciphex for research and clinical trials, pairing specialist pathologists with an image management system and AI analysis. | Talk Wed Oct 7 3:00pm Pathology Reimagined: Expert Insight & Intelligent Tools for Companion Diagnostic & Biomarker Trials Digital pathology & spatial biomarkersClinical & companion diagnostic development |
Promise Bio Tel Aviv, Israel | ◇Spotlight Partner |
Israeli start-up whose cloud AI platform reads standard mass spectrometry data to map protein modifications, for biomarker discovery and patient selection in autoimmune disease. | Talk Wed Oct 7 12:40pm Broad PTM Resolution for the Next Era of Biomarker Discovery Biomarker discovery & translation |
Sonrai Analytics Belfast, UK | ◇Program Partner |
Belfast company offering a data analysis platform and scientist-led analytics that combine molecular, imaging and clinical data for biomarker discovery and patient stratification. | Talk Thu Oct 8 11:50am LymphoSight: Quantifying Immune Contexture in Clinical Trials with Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
◇Expertise Partner | |
Healthcare technology company whose cloud SaaS platform, SOPHiA DDM, analyzes genomic and other multimodal data for hospitals, labs and drug developers. | Talk Tue Oct 6 5:40pm The Power of Modular CGP: Enabling Precision Oncology Across Drug Development Clinical & companion diagnostic development |
 Amazon Web Services Seattle, WA | |
Amazon's cloud computing business, offering compute, storage, data and AI services used by life science and healthcare companies. | Panel Wed Oct 7 12:50pm Embed, Don’t Disrupt: AI Diagnostics That Scale Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access |
Google's cloud computing business, offering data, infrastructure and AI services to healthcare and life science companies. | Panel Wed Oct 7 3:10pm Realizing the Promise, Gaps & Platform Innovation for Precision Medicine at Scale from Global Technology Leaders Multimodal & AI-enabled precision medicine |
◇Exhibition Partner | |
Trains AI models for specific diseases on human biological data gathered with US academic medical centers, for diagnostics, biomarker discovery and drug development. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
PathAI Boston, MA | ◇Program Partner |
AI pathology company whose platform analyzes tissue images for pathologists, researchers and drug developers. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
PredxBio Pittsburgh, PA | ◇Meeting Partner |
Software company whose SpaceIQ platform combines tissue morphology with spatial multiomic data for biomarker discovery, patient stratification and CDx development. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Zephyr AI McLean, VA | ◇Meeting Partner |
AI software that forecasts how cancer patients respond to drugs and infers gene expression from routine DNA test results, aiding patient selection and trial design. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Instantly find 20 buyers from software, data and AI companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World CDx 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction